Toward Developing Clinical cut-off for the Grandiosity Scale of the Dimensional Clinical Personality Inventory 2

Lucas de Francisco Carvalho, Catarina Possenti Sette, Ariela Raissa Lima Costa
{"title":"Toward Developing Clinical cut-off for the Grandiosity Scale of the Dimensional Clinical Personality Inventory 2","authors":"Lucas de Francisco Carvalho,&nbsp;Catarina Possenti Sette,&nbsp;Ariela Raissa Lima Costa","doi":"10.1016/j.rcpeng.2020.11.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The present study aims to establish a clinical cut-off for the Grandiosity dimension, using item-level evaluation procedures.</p></div><div><h3>Methods</h3><p>Participants were 5,387 adults, including outpatients diagnosed with narcissistic personality disorder (NPD), outpatients diagnosed with other personality disorders, and adults from the community. We administered the self-reported Grandiosity scale from the Dimensional Clinical Personality Inventory 2 (IDCP-2). The equating procedure was applied to generate theta scores for participants who did not answer all items.</p></div><div><h3>Results</h3><p>The Wright map revealed that outpatients scored high on the latent continuum of the Grandiosity scale. Group comparison showed large effect sizes for the mean difference between patients and non-patients. The ROC curve supports a cut off at a –0.45 score in theta standardisation, which yields a high sensitivity (91%) and moderate specificity (58%). Moreover, the PPP (71%) and NPP (79%) values suggest that the scale is able to identify NPD patients in 71% of cases, and people without NPD in 79% of cases.</p></div><div><h3>Conclusions</h3><p>The findings suggest the IDCP-2 Grandiosity scale is useful as an NPD screening tool. Possible clinical applications for the scale are described and the limitations of the study are discussed.</p></div>","PeriodicalId":74702,"journal":{"name":"Revista Colombiana de psiquiatria (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Colombiana de psiquiatria (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2530312022000637","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective

The present study aims to establish a clinical cut-off for the Grandiosity dimension, using item-level evaluation procedures.

Methods

Participants were 5,387 adults, including outpatients diagnosed with narcissistic personality disorder (NPD), outpatients diagnosed with other personality disorders, and adults from the community. We administered the self-reported Grandiosity scale from the Dimensional Clinical Personality Inventory 2 (IDCP-2). The equating procedure was applied to generate theta scores for participants who did not answer all items.

Results

The Wright map revealed that outpatients scored high on the latent continuum of the Grandiosity scale. Group comparison showed large effect sizes for the mean difference between patients and non-patients. The ROC curve supports a cut off at a –0.45 score in theta standardisation, which yields a high sensitivity (91%) and moderate specificity (58%). Moreover, the PPP (71%) and NPP (79%) values suggest that the scale is able to identify NPD patients in 71% of cases, and people without NPD in 79% of cases.

Conclusions

The findings suggest the IDCP-2 Grandiosity scale is useful as an NPD screening tool. Possible clinical applications for the scale are described and the limitations of the study are discussed.

多维临床人格量表中夸大度量表的临床截点研究2
目的本研究旨在运用项目级评估程序,建立一个关于夸大维度的临床分界点。方法研究对象为5387名成人,包括自恋型人格障碍门诊患者、其他类型人格障碍门诊患者和来自社区的成人。本研究采用临床人格量表2 (IDCP-2)中的自我报告性自大量表。对于没有回答所有问题的参与者,应用等号程序生成theta分数。结果Wright图显示门诊患者在夸大程度的潜在连续统上得分较高。组间比较显示,患者和非患者之间的平均差异有很大的效应值。ROC曲线在theta标准化得分为-0.45时支持截断,这产生了高灵敏度(91%)和中等特异性(58%)。此外,PPP(71%)和NPP(79%)值表明,该量表能够识别71%的NPD患者和79%的非NPD患者。结论IDCP-2量表可作为NPD的筛查工具。描述了该量表可能的临床应用,并讨论了本研究的局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信